Genomic analysis of benign prostatic hyperplasia implicates cellular relandscaping in disease pathogenesis

Abstract excerpt

Benign prostatic hyperplasia (BPH) is the most common cause of lower urinary tract symptoms in men. Current treatments target prostate physiology rather than BPH pathophysiology and are only partially effective. Here, we applied next-generation sequencing to gain new insight into BPH. By RNAseq, we uncovered transcriptional heterogeneity among BPH cases, where a 65-gene BPH stromal signature correlated with...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Prostate Cancer Diagnosis and Treatment
• Share to Prostate Cancer Treatment and Research
• Share to Urologic and reproductive health conditions